Prosstatin (Biotherapies)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameProsstatin (Biotherapies)
Drug Alias Nameprostate cancer therapy (Biotherapies)prostate hyperplasia therapy (Biotherapies)prostate tumor therapy (Biotherapies)
ClassificationBiologics > Protein drugs > Recombinant polypeptideDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic HyperplasiaProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotherapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotherapies Inc
Active IndicationsN/A
Inactive IndicationsProstatic HyperplasiaProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A